Strategy to avoid local recurrence in patients with locally advanced rectal cancer

[1]  Masaaki Ito,et al.  Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial , 2017, Annals of surgery.

[2]  J. Lim,et al.  A Randomized Phase 2 Study of Neoadjuvant Chemoradiaton Therapy With 5-Fluorouracil/Leucovorin or Irinotecan/S-1 in Patients With Locally Advanced Rectal Cancer. , 2015, International journal of radiation oncology, biology, physics.

[3]  R. Beart,et al.  Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial. , 2015, Journal of the National Cancer Institute.

[4]  T. Hothorn,et al.  Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. , 2015, The Lancet. Oncology.

[5]  Joon-Oh Park,et al.  Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial. , 2014, The Lancet. Oncology.

[6]  K. Yamashita,et al.  Neoadjuvant chemoradiation therapy using concurrent S-1 and irinotecan in rectal cancer: impact on long-term clinical outcomes and prognostic factors. , 2014, International journal of radiation oncology, biology, physics.

[7]  J. Park,et al.  Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. , 2014, The Lancet. Oncology.

[8]  T. Beißbarth,et al.  Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  M. Gonen,et al.  Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  L. Collette,et al.  Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. , 2014, The Lancet. Oncology.

[11]  H. Kuroyanagi,et al.  Laparoscopic surgery for rectal cancer: Current status and future perspective , 2014, Asian journal of endoscopic surgery.

[12]  S. Larson,et al.  Neither FDG-PET Nor CT Can Distinguish Between a Pathological Complete Response and an Incomplete Response After Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Prospective Study , 2013, Annals of surgery.

[13]  T. Conroy,et al.  Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  W. Hohenberger,et al.  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Hein Putter,et al.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. , 2011, The Lancet. Oncology.

[16]  K. Yamashita,et al.  A Phase II trial of neoadjuvant preoperative chemoradiotherapy with S-1 plus irinotecan and radiation in patients with locally advanced rectal cancer: clinical feasibility and response rate. , 2011, International journal of radiation oncology, biology, physics.

[17]  N. Petrelli,et al.  Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  I. Okayasu,et al.  Phase I trial of neoadjuvant preoperative chemotherapy with S-1 and irinotecan plus radiation in patients with locally advanced rectal cancer. , 2007, International journal of radiation oncology, biology, physics.

[19]  L. Påhlman,et al.  Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. Macfarlane,et al.  Mesorectal excision for rectal cancer , 1993, The Lancet.

[21]  T. Muto,et al.  Selective Lateral Pelvic Lymph Node Dissection in Patients with Advanced Low Rectal Cancer Treated with Preoperative Chemoradiotherapy Based on Pretreatment Imaging , 2013, Annals of Surgical Oncology.

[22]  O. Dworak,et al.  Pathological features of rectal cancer after preoperative radiochemotherapy , 1997, International Journal of Colorectal Disease.